World Sleep Industry ENCYCLOPEDIA

Sleep Algorithm Evaluation Services

4.4.3

Definition, targets, and evaluation boundaries

Sleep algorithm evaluation services use an appropriately independent internal group or third party to test, evaluate, validate, and interpret a locked version of a sleep algorithm, software component, or human–machine system. They fall under WSIC 4.4.3, Sleep Data Services. Targets may include sleep–wake detection, sleep staging, arousal and respiratory or movement event detection, estimates such as total sleep time and AHI, continuous SpO₂ and heart-rate measurement, snoring or position classification, bed occupancy and exit detection, risk prediction, and quality rejection. The service asks whether an identified version meets predefined requirements for a stated population, device, input, and workflow; it does not award a context-free certification.

Evaluation should distinguish scientific or clinical association, analytical or technical performance, clinical performance, and the effect of system use. Accurate generation of a number does not establish that the number has a valid association with a target health state. Good offline case-level performance does not by itself establish safety, efficiency, or improved outcomes after integration with devices, interfaces, and human review. Research prototypes, consumer wellness feedback, clinical decision support, and occupational safety alerts have different risks and evidence needs. The report must limit the claims it supports and identify regulatory, clinical-study, usability, and real-world questions outside scope.

Protocol pre-specification, version locking, and independence

Before test outcomes are inspected, the protocol should freeze intended use, target population, setting, input channels and devices, sampling and preprocessing, prediction unit, output definition, reference standard, threshold, ignored regions, event-matching logic, primary and secondary metrics, subgroups, sample-size rationale, missing-data handling, and acceptance criteria. If the client selects a new threshold, removes difficult cases, or changes the primary metric after disappointing results, the original test has become development activity and confirmation requires independent data. Exploratory analyses may remain useful but should be clearly separated from confirmatory conclusions.

The test article needs a reproducible fingerprint spanning source or binary, model weights, features and preprocessing, thresholds and postprocessing, dependencies, container, runtime, random seeds, hardware, and device or firmware version. Inputs, labels, splits, and scoring code also require version locks. Evaluators should not be the front-line model tuners, and conflicts and sponsorship should be disclosed. Access to test labels and case-level feedback and the number of queries should be limited so repeated submissions do not overfit the hidden set. An evaluator that also provides training services needs personnel, data, and decision separation.

Test data, reference standards, and statistical design

The test set should be independent of training, tuning, and early experiments at participant level. Multiple nights, overlapping windows, repeat exports, derived records, and household relationships need inspection. Public cohorts may have entered pretraining or development through mirrors and renamed copies, so filename comparison is not an adequate contamination check. The test population and acquisition conditions should cover age, sex, condition and severity, comorbidity, center, geography, device, home or laboratory setting, and signal quality relevant to the stated use. Separate stress sets can address new centers, devices, later time periods, and poor-quality input. Sample size should reflect independent participants, event counts, rare classes, clustering, and target uncertainty rather than using huge epoch counts to conceal a small population.

Reference results may come from qualified scorers, expert consensus, a synchronized reference device, clinical outcomes, or a validated method, but must match the target output. The evaluation should document the scoring rules and version, scorer qualifications, blinding, independent review, adjudication, device calibration, temporal tolerance, and indeterminate regions. Human sleep scoring has structured disagreement around N1, transitions, artifact, and event boundaries, so one scorer is not infallible ground truth. Multiple-rater distributions, confidence, or unresolved labels can be retained and reference error explored through sensitivity analysis. Agreement with labels that were generated using the same model as a pre-labeling aid is not fully independent evidence.

Task metrics, uncertainty, and error interpretation

Metrics need to match the prediction unit and cost of error. Sleep staging may report macro F1, per-stage sensitivity and positive predictive value, agreement, confusion, transition performance, and night-level error in total sleep time, sleep efficiency, and stage proportions. Event detection requires prespecified matching and may report event sensitivity, positive predictive value, false alarms per hour, onset and offset error, and duration. Night-level measures such as AHI or REI require continuous-value error, severity-category agreement, and reclassification near clinical thresholds. Continuous vital signs require error distributions, bias, coverage, and unavailable output; correlation alone is insufficient. Risk models also need discrimination, calibration, threshold-specific errors, and decision consequences.

Confidence intervals and significance tests should use the participant as the principal independent unit and account for repeated nights, center clustering, and multiple comparisons. Results should include denominators, failed inputs, rejection, packet loss, and unavailable-output rates; computing accuracy only among successful outputs causes selection bias. Overall results should be stratified by prespecified subgroup, device, center, signal quality, night period, and disease severity, with uncertainty shown for small samples. Error review should cover worst cases, threshold regions, transitions, rare events, and systematic confusions, and distinguish statistical significance from practical clinical effect. If a composite score is used, its components and weights must be public, and frequent easy items must not offset high-risk errors.

Robustness, fairness, and human workflow

Robustness tests should reflect reasonably foreseeable variation: noise, movement, low perfusion, detached sensors, missing channels, alternative leads or placement, changes in sampling and compression, clock misalignment, firmware, environmental interference, and distribution shift. Evaluation should determine whether the algorithm recognizes out-of-scope input, expresses uncertainty or rejection, invokes review, and remains stable across repeat runs and permitted hardware. Real-time systems also need latency, throughput, memory, energy, network recovery, queue backlog, and interface-error tests. Security testing may cover malicious or malformed inputs according to risk, but passing attack tests does not replace validation under ordinary clinical conditions.

Fairness does not require identical metrics in every subgroup; it requires adequate evidence across the claimed population, explained differences, and acceptable risk. Relevant groups may combine age, sex, skin-tone-related sensing effects, condition, severity, comorbidity, center, device, and environment. Intersections and small samples require uncertainty, and “not significant” does not prove no difference. If a technologist or clinician uses the system, the evaluator should compare algorithm alone, person alone, and collaboration, examining correction, review time, automation bias, alert fatigue, coverage, escalation, and final responsibility. Interface presentation and training can change system outcomes, so model-level scores cannot replace end-to-end workflow evaluation.

Secure execution, deliverables, and result governance

Evaluation may run on an isolated server, in a trusted workspace, or inside the client environment to protect sensitive health data, hidden labels, and model intellectual property. The environment should restrict unnecessary networking and export and apply least privilege, key management, input and output review, malicious-model safeguards, logging, and deletion at expiry. Every run should retain model and data hashes, configuration, time, hardware, exit status, and scoring version. The evaluator must guard against a model encoding test data in its outputs, while the client must not attempt to infer identities or hidden labels or bypass submission limits through multiple accounts.

Deliverables should include the prespecified protocol, test-article fingerprint, data source and representation, inclusion and exclusion, reference standard, statistical methods, primary and subgroup results, uncertainty, failure modes, unresolved risks, protocol deviations, and reproducible execution records. Conclusions should distinguish met, unmet, and insufficient evidence and constrain promotional language to tested scope. Contracts also need to address price, timing, intellectual property, test-data confidentiality, publication rights, negative findings, conflicts, appeals, independent review, and retention. A leaderboard rank or pass mark must not hide the dataset version, comparator, or threshold and should not imply regulatory approval or real-world effectiveness.

Change management, continuous monitoring, and procurement judgment

Changes to weights, architecture, training data, preprocessing, thresholds, postprocessing, firmware, sensors, interfaces, target population, or workflow may invalidate an earlier conclusion. The project should establish a change-impact classification in advance, specifying when regression testing, a bridging evaluation, targeted subgroup confirmation, or full reevaluation is required, and preserve before-and-after evidence. Iterative systems also need bounded changes, validation methods, acceptance criteria, and a mechanism to stop or roll back an implementation that fails. Post-deployment monitoring should track input quality and distribution, rejection, subgroup performance, human overrides, incidents, and outcome drift, but uncontrolled real-world feedback must not flow directly into model updates.

Purchasers should examine the evaluator’s independence, sleep-domain and statistical competence, participant-level isolation, source-format and device experience, reference-standard governance, secure environment, and reproducibility, and calibrate the plan with representative cases. Pricing should distinguish protocol design, data licensing, expert labeling, controlled execution, statistical analysis, workflow testing, and monitoring; a cheap one-time score is not a complete evaluation. Results are one part of a deployment decision, alongside intended-use risk, regulation, privacy, cybersecurity, usability, operations, and alternatives. Where evidence is insufficient or failure risk is unacceptable, the appropriate outcome may be restricted use, additional human review, new data, or no deployment.